Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

Latest News

New Zealand leader excited for holiday break with infant

Dec 17, 2018

WELLINGTON, New Zealand — New Zealand's Prime Minister Jacinda Ardern says that six months after giving birth, she's looking forward to spending more time with her daughter Neve over the Christmas break and thanking everybody who's helped her juggle responsibilities. Ardern spoke to The Associated Press on Monday as she carried around a box to hand-deliver holiday treats of coffee and peanut brittle to reporters at Parliament. She was keeping alive a tradition in New Zealand that would be hard to imagine in some countries due to the sometimes acrimonious relationships between journalists and politicians. Ardern is just the second...

Australia recognizes west Jerusalem as Israel's capital

Dec 17, 2018

SYDNEY — Australia has decided to formally recognize west Jerusalem as Israel's capital, but won't move its embassy until there's a peace settlement between Israel and the Palestinians, Prime Minister Scott Morrison announced Saturday. Morrison said in a speech that Australia would recognize east Jerusalem as Palestine's capital only after a settlement has been reached on a two-state solution. The Australian Embassy won't be moved from Tel Aviv until such a time, he said. While the embassy move is delayed, Morrison said his government would establish a defense and trade office in Jerusalem and would also start looking for an...

New Zealand law to make medical marijuana widely available

Dec 17, 2018

WELLINGTON, New Zealand — New Zealand's government on Tuesday passed a law that will make medical marijuana widely available for thousands of patients over time. The legislation will also allow terminally ill patients to begin smoking illegal pot immediately without facing the possibility of prosecution. The measures come ahead of a planned national referendum on recreational marijuana use. The government has pledged to hold the referendum some time over the next two years, but has not yet set a date or finalized the wording. The new law allows patients much broader access to medical marijuana, which was previously highly restricted....

Australian PM accuses Muslim leaders of denying threat

Dec 17, 2018

CANBERRA, Australia — Australia's prime minister accused senior Muslim community leaders on Wednesday of "continuing down a path of denial" after they refused an invitation to a meeting to discuss the threat posed by Islamic extremists. Prime Minister Scott Morrison's tweeted response to the Islamic leaders' request for a postponement of Thursday's meeting adds to friction with the Muslim world sparked by his proposal last month to move the Australian embassy in Israel from Tel Aviv to Jerusalem. Morrison has denied a widely held view that the Jerusalem proposal was aimed at domestic political gain amid a debate over levels...

Police storm Papua New Guinea Parliament for APEC summit pay

Dec 17, 2018

PORT MORESBY, Papua New Guinea — Disgruntled police, military and prison guards stormed Papua New Guinea's Parliament on Tuesday in a violent pay dispute stemming from an international summit hosted by the impoverished South Pacific island nation over the weekend, a lawmaker said. Images posted by opposition lawmaker Bryan Kramer on social media showed broken windows, smashed furniture, pictures torn from walls and plants tipped over. Parliament's security check point including a metal detector was trashed and doors were destroyed along with their fingerprint-reading locking systems, Kramer said. He said the protesters had not been paid their promised allowances for...

Stock Markets

About Us

The Morning Herald is a fast news provider in the United States since 2005. Fiercely independent and armed with irreverent intelligence, there’s no other place to get your news other than The Morning Herald.

Contact us: sales[at]themorningherald.com

Subscribe Now!